Results 91 to 100 of about 98,224 (178)

Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokinetics

, 2013
Shilin Ma,1 Fen Chen,1 Xiaohui Ye,2 Yingjie Dong,2 Yingna Xue,1 Heming Xu,1 Wenji Zhang,1 Shuangshuang Song,1 Li Ai,2 Naixian Zhang,2 Weisan Pan1 1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 2Liaoning Institute of Pharmaceutical ...
Zhang W, Pan W, Ma S, Dong Y, Chen F, Song S, Zhang N, Ai L, Xu H, Ye X, Xue Y   +10 more
core  

Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. [PDF]

Int J Biol Sci
Chen X, Shen J, Xu Z, Xu B, Huang J, Jiang J, Chen Y, Li X, Yang S, Wu K, Wang J, Luo P, He Q, Ma S, Xia B, Yang B.   +15 more
europepmc   +1 more source

Refractory thrombocytopenia induced by enzalutamide combined with docetaxel chemotherapy in a metastatic castration-resistant prostate cancer patient with bone marrow metastasis: a case report and literature review. [PDF]

Front Oncol
Chen Y, Liu J.
europepmc   +1 more source

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024. [PDF]

Oncologist
Raval AD, Mpima S, Casey V, Manuguid F, Korn M, Castro E.   +5 more
europepmc   +1 more source

Combination Treatment of Docetaxel Liposomes and Sonodynamic Therapy With Verteporfin Liposomes in Patients With Cancer: A Report of Three Cases. [PDF]

Case Rep Oncol Med
Komura Y, Kimura S, Hirasawa Y, Takasaki R, Fukuro S, Thi NTM, Gengou M, Woo LS, Imataki O, Yanagawa T, Homma K.   +10 more
europepmc   +1 more source

Discordant Cavitary Changes: A Radiological Dilemma in Invasive Mucinous Adenocarcinoma: A Case Report. [PDF]

Respirol Case Rep
Nigi A, Miya N, Iwamoto K, Itani H, Kondou S.   +4 more
europepmc   +1 more source

Toxic erythema of chemotherapy presenting at scar and conventional sites: An atypical distribution. [PDF]

Indian J Pharmacol
Meena A, Vimala TS, Srinivas BH, Ramassamy S.   +3 more
europepmc   +1 more source

Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy. [PDF]

Pharmaceutics
Albatsh M, Al-Quraishi Z, Laskar P, Somani S, Irving C, Mackenzie GR, Woods S, Roberts CW, Mullin M, Dufès C.   +9 more
europepmc   +1 more source

Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody-Drug Conjugates. [PDF]

Cancers (Basel)
Sharaf B, Al-Rwashdeh M, El Khatib O, Al-Ibraheem A, Abu Fara A, Ismail A, Alkasrawi H, Abdalla M, Jehad S.   +8 more
europepmc   +1 more source

Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database. [PDF]

Front Oncol
Zhang Q, Feng Q, Lei S, Yang W, Zhang W, Liu X.   +5 more
europepmc   +1 more source